Type to search

Imfinzi Plus Chemotherapy Tripled Patient Survival at Three Years in the CASPIAN Phase III Trial in Extensive-stage Small Cell Lung Cancer | Pharmtech Focus
FDA Approves Tissue-Based NGS Companion Diagnostic for Takeda's Targeted Therapy for NSCLC Patients with EGFR Exon20 Insertion Mutations | Pharmtech Focus
New Chemotherapy-free Treatment for Bowel Cancer Made Available in Scotland | Pharmtech Focus